GR3033768T3 - Use of dopamine receptor antagonists in palliative tumor therapy - Google Patents
Use of dopamine receptor antagonists in palliative tumor therapyInfo
- Publication number
- GR3033768T3 GR3033768T3 GR20000401464T GR20000401464T GR3033768T3 GR 3033768 T3 GR3033768 T3 GR 3033768T3 GR 20000401464 T GR20000401464 T GR 20000401464T GR 20000401464 T GR20000401464 T GR 20000401464T GR 3033768 T3 GR3033768 T3 GR 3033768T3
- Authority
- GR
- Greece
- Prior art keywords
- receptor antagonists
- dopamine receptor
- tumor therapy
- palliative
- palliative tumor
- Prior art date
Links
- 229940121891 Dopamine receptor antagonist Drugs 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000003210 dopamine receptor blocking agent Substances 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 3
- 229940121683 Acetylcholine receptor antagonist Drugs 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 abstract 1
- 229960001253 domperidone Drugs 0.000 abstract 1
- PQLXHQMOHUQAKB-UHFFFAOYSA-N miltefosine Chemical compound CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C PQLXHQMOHUQAKB-UHFFFAOYSA-N 0.000 abstract 1
- 229960003775 miltefosine Drugs 0.000 abstract 1
- YVUQSNJEYSNKRX-UHFFFAOYSA-N pimozide Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)CCCN1CCC(N2C(NC3=CC=CC=C32)=O)CC1 YVUQSNJEYSNKRX-UHFFFAOYSA-N 0.000 abstract 1
- 229960003634 pimozide Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19650778A DE19650778C2 (de) | 1996-12-06 | 1996-12-06 | Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3033768T3 true GR3033768T3 (en) | 2000-10-31 |
Family
ID=7813911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR20000401464T GR3033768T3 (en) | 1996-12-06 | 2000-06-23 | Use of dopamine receptor antagonists in palliative tumor therapy |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6093704A (el) |
| EP (1) | EP0858807B1 (el) |
| JP (1) | JPH10167969A (el) |
| AT (1) | ATE192044T1 (el) |
| BR (1) | BR9706229A (el) |
| CA (1) | CA2223469C (el) |
| DE (2) | DE19650778C2 (el) |
| DK (1) | DK0858807T3 (el) |
| ES (1) | ES2146063T3 (el) |
| GR (1) | GR3033768T3 (el) |
| PT (1) | PT858807E (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2005105693A (ru) * | 2002-07-30 | 2005-07-10 | Центарис ГмбХ (DE) | Применение алкилфосфохолинов и лекарственное средство для лечения опухолевых заболеваний |
| US8383605B2 (en) * | 2002-07-30 | 2013-02-26 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| AR058397A1 (es) | 2005-12-19 | 2008-01-30 | Zentaris Gmbh | Derivados de alquilfosfolipidos con citotoxicidad reducida y usos de los mismos |
| US8835506B2 (en) | 2008-06-05 | 2014-09-16 | Stc.Unm | Methods and related compositions for the treatment of cancer |
| MX2011011596A (es) | 2010-03-31 | 2012-02-01 | Keryx Biopharmaceuticals Inc | Perifosina y capecitabina como un tratamiento combinado para cancer. |
| KR102500766B1 (ko) | 2017-12-29 | 2023-02-17 | 삼성전자주식회사 | 생체 신호 측정 장치 및 그의 동작 방법 |
| KR102203334B1 (ko) * | 2019-04-12 | 2021-01-15 | 성균관대학교산학협력단 | 피모자이드의 항암제 병용요법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4707484A (en) * | 1986-11-25 | 1987-11-17 | Hoffmann-La Roche Inc. | Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives |
| JPS6483016A (en) * | 1987-09-25 | 1989-03-28 | Arakawa Chem Ind | Regulator for motile function of gastrointestinal tract |
| WO1997005129A1 (fr) * | 1995-07-28 | 1997-02-13 | Dainippon Pharmaceutical Co., Ltd. | (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, son procede d'obtention et medicament le contenant |
-
1996
- 1996-12-06 DE DE19650778A patent/DE19650778C2/de not_active Expired - Fee Related
-
1997
- 1997-11-29 AT AT97121009T patent/ATE192044T1/de not_active IP Right Cessation
- 1997-11-29 EP EP97121009A patent/EP0858807B1/de not_active Expired - Lifetime
- 1997-11-29 DK DK97121009T patent/DK0858807T3/da active
- 1997-11-29 DE DE59701508T patent/DE59701508D1/de not_active Expired - Fee Related
- 1997-11-29 ES ES97121009T patent/ES2146063T3/es not_active Expired - Lifetime
- 1997-11-29 PT PT97121009T patent/PT858807E/pt unknown
- 1997-12-03 JP JP9332646A patent/JPH10167969A/ja active Pending
- 1997-12-04 CA CA002223469A patent/CA2223469C/en not_active Expired - Fee Related
- 1997-12-04 BR BR9706229A patent/BR9706229A/pt not_active Application Discontinuation
- 1997-12-05 US US08/986,235 patent/US6093704A/en not_active Expired - Lifetime
-
2000
- 2000-06-23 US US09/599,561 patent/US6576624B1/en not_active Expired - Fee Related
- 2000-06-23 GR GR20000401464T patent/GR3033768T3/el not_active IP Right Cessation
-
2002
- 2002-08-02 US US10/210,881 patent/US6696428B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE59701508D1 (de) | 2000-05-31 |
| JPH10167969A (ja) | 1998-06-23 |
| EP0858807A3 (de) | 1999-03-24 |
| US6576624B1 (en) | 2003-06-10 |
| US6696428B2 (en) | 2004-02-24 |
| CA2223469A1 (en) | 1998-06-06 |
| EP0858807B1 (de) | 2000-04-26 |
| US20030008846A1 (en) | 2003-01-09 |
| CA2223469C (en) | 2005-08-23 |
| EP0858807A2 (de) | 1998-08-19 |
| ES2146063T3 (es) | 2000-07-16 |
| BR9706229A (pt) | 1999-05-04 |
| DE19650778C2 (de) | 2001-01-04 |
| PT858807E (pt) | 2000-09-29 |
| US6093704A (en) | 2000-07-25 |
| DK0858807T3 (da) | 2000-07-31 |
| ATE192044T1 (de) | 2000-05-15 |
| DE19650778A1 (de) | 1998-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142921A0 (en) | USES FOR Eph RECEPTOR ANTAGONISTS AND AGONISTS TO TREAT VASCULAR DISORDERS | |
| FR13C0062I1 (el) | ||
| YU20600A (sh) | Nova upotreba antagonista 5-ht3 receptora | |
| HK1064614A1 (en) | Use of methylnaltrexone to treat immune suppression | |
| HK1094148A1 (en) | Synergistic therapeutic compositions and methods | |
| TR199801315T2 (xx) | X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�. | |
| HUT74992A (en) | Use of serotonin antagonist indol derivatives for producing pharmaceutical compositions using for treating fibromyalgia | |
| GR3035971T3 (en) | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents. | |
| MXPA05010819A (es) | Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable. | |
| MY110217A (en) | Use of l-deprenyl for retarding deterioration due to aging in dogs | |
| EP0771147A4 (en) | METHOD AND COMPOSITIONS FOR INCREASED TUMOR CELL IMMUNITY IN VIVO | |
| PL347671A1 (en) | Compounds and compositions for delivering active agents | |
| ZA988139B (en) | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy. | |
| GR3033768T3 (en) | Use of dopamine receptor antagonists in palliative tumor therapy | |
| ES2194222T3 (es) | Dispositivo para la administracion asistida electricamente de agentes tales como lidocaina y epinefrina. | |
| IL132853A0 (en) | Combination therapy for modulating the human sexual response | |
| HUP0101528A3 (en) | The treatment of fertility disorders use of lhrh antagonists and antioestrogens in | |
| EP0906108A4 (en) | METHOD FOR TREATING HEART FAILURE WITH ENDOTHELINE ANTAGONIST. | |
| HU9700661D0 (en) | Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer | |
| ZA988009B (en) | Methods of administering an ampa receptor antagonist to treat dyskinesias associated with dopamine agonist therapy. | |
| AU8548291A (en) | Menthol derivative having spasmolytic activity | |
| TR199801800T2 (xx) | Uykusuzluk tedavisi. | |
| UA11773A1 (uk) | Засіб для стимулюваhhя та сиhхроhізації пологової діяльhості у свиhоматок |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ML | Lapse due to non-payment of fees |